Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review
Antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV transmission was first
approved by the US Food and Drug Administration in 2012. Despite correlations of …
approved by the US Food and Drug Administration in 2012. Despite correlations of …
Social-ecological barriers to access to healthcare for adolescents: a scoping review
Access to healthcare for adolescents is often overlooked in the United States due to federal
and state-sponsored insurance programs such as Medicaid and the Children's Health …
and state-sponsored insurance programs such as Medicaid and the Children's Health …
A gap between willingness and uptake: findings from mixed methods research on HIV prevention among black and Latina transgender women
Background: Black and Latina transgender women (BLTW) face significant HIV disparities
with estimated HIV prevalence up to 50% and annual incidence rates as high as 2.8 per 100 …
with estimated HIV prevalence up to 50% and annual incidence rates as high as 2.8 per 100 …
Is insurance a barrier to HIV preexposure prophylaxis? Clarifying the issue
Clinical trials have demonstrated that preexposure prophylaxis (PrEP) protects against HIV
infection; yet, even with its approval by the Food and Drug Administration (FDA) in 2012 …
infection; yet, even with its approval by the Food and Drug Administration (FDA) in 2012 …
Pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM): a scoping review on PrEP service delivery and programming
Pre-exposure prophylaxis (PrEP) is an evidence-based new biomedical HIV prevention
intervention, which involves the pre-emptive use of daily (or event-based) antiretroviral …
intervention, which involves the pre-emptive use of daily (or event-based) antiretroviral …
HIV pre-exposure prophylaxis implementation cascade among health care professionals in the United States: implications from a systematic review and meta-analysis
Although pre-exposure prophylaxis (PrEP) has been approved for primary HIV prevention
for individuals aged 18 years or older since 2012, PrEP utilization has been suboptimal. To …
for individuals aged 18 years or older since 2012, PrEP utilization has been suboptimal. To …
[HTML][HTML] HIV preexposure prophylaxis and treatment as prevention—beliefs and access barriers in men who have sex with men (MSM) and transgender women: a …
JJ Matacotta, FJ Rosales-Perez… - Journal of Patient …, 2020 - ncbi.nlm.nih.gov
Purpose While the annual rate of new HIV infections and diagnoses has remained stable for
most groups, troubling increases are seen in transgender women and racial/ethnic-minority …
most groups, troubling increases are seen in transgender women and racial/ethnic-minority …
PrEP awareness, uptake, barriers, and correlates among adolescents assigned male at birth who have sex with males in the US
K Macapagal, A Kraus, AK Korpak, K Jozsa… - Archives of sexual …, 2020 - Springer
Abstract In May 2018, the US Food and Drug Administration approved daily oral pre-
exposure prophylaxis (PrEP) for adolescents under age 18. Although this is an important …
exposure prophylaxis (PrEP) for adolescents under age 18. Although this is an important …
Role of structural marginalization, HIV stigma, and mistrust on HIV prevention and treatment among young Black Latinx men who have sex with men and transgender …
R Arrington-Sanders, K Hailey-Fair… - AIDS patient care and …, 2020 - liebertpub.com
Young black and Latinx men who have sex with men (YBLMSM) and transgender women
(YBLTW) are disproportionately impacted by HIV. Structural and social marginalization, the …
(YBLTW) are disproportionately impacted by HIV. Structural and social marginalization, the …
Considering stigma in the provision of HIV pre-exposure prophylaxis: Reflections from current prescribers
SK Calabrese, M Tekeste, KH Mayer… - AIDS patient care and …, 2019 - liebertpub.com
Efforts to identify and address social inequities in HIV pre-exposure prophylaxis (PrEP)
access are urgently needed. We investigated early-adopting PrEP prescribers' beliefs about …
access are urgently needed. We investigated early-adopting PrEP prescribers' beliefs about …